Seyed Kazem Shakouri

Prof. Seyed Kazem Shakouri


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2020 in Iranian Journal of Allergy, Asthma and Immunology
Verified
Journal Article
Open access
PDF file
APAlireza Pishgahi
Alireza Pishgahi
RARozita Abolhasan
Rozita Abolhasan
SSSeyed Kazem Shakouri
Seyed Kazem Shakouri
MSMohammad Sadegh Soltani-Zangbar
Mohammad Sadegh Soltani-Zangbar
SDShahla Dareshiri
Shahla Dareshiri
MYMehdi Yousefi
Mehdi Yousefi
Knee osteoarthritis (OA) is one of the common degenerative articular disorders that are related to decreased quality of life. Currently, novel biologic therapeutic approaches are introduced in the literature for OA management. In this study, the clinical efficiency of Dextrose prolotherapy, platelet-rich plasma (PRP) and autologous conditioned serum (ACS) injection on the level of pain and function in Knee OA were compared. A randomized clinical trial was directed on 92 knee OA patients. Patients were randomly divided into three groups: 30 were received dextrose prolotherapy once in a week for three weeks, 30 received autologous PRP for two times with seven days interval, and in the remaining 32 patients 2ml of ACS were injected two times every seven days. Study participants were measured through the Western Ontario and McMaster Universities (WOMAC) score, the visual analogue scale (VAS), at baseline, 1 and 6 months post-intervention. Both ACS and PRP treated patients showed improvement in pain intensity and knee function during 1 and 6 months pursue; however, this progress was more significant in the ACS group. Dextrose prolotherapy showed no substantial changes in pain and function of the affected knee in treated patients. Treatment of Knee OA with ACS and PRP injections are associated with pain reduction and knee function improvement. Not only, ACS therapy is more effective than that of PRP, but also due to its less variability in processing and less reported side effects, it could be considered as a safe and effective non-surgical alternative for OA management.

4 November 2011 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
FEFariba Eslamian
Fariba Eslamian
SSSeyed Kazem Shakouri
Seyed Kazem Shakouri
MGMorteza Ghojazadeh
Morteza Ghojazadeh
ONOzra Eslampanah Nobari
Ozra Eslampanah Nobari
BEBina Eftekharsadat
Bina Eftekharsadat

1 October 2018 in Journal of Acupuncture and Meridian Studies
Verified
Journal Article
Open access
BEBina Eftekharsadat
Bina Eftekharsadat
EPElmira Porjafar
Elmira Porjafar
FEFariba Eslamian
Fariba Eslamian
SSSeyed Kazem Shakouri
Seyed Kazem Shakouri
HFHamid Reza Fadavi
Hamid Reza Fadavi
ABArash Babaei-Ghazani
Arash Babaei-Ghazani
Myofascial pain syndrome (MPS) is a common musculoskeletal disorder. This study was designed to compare the effects of aerobic exercise plus acupuncture with acupuncture alone in treatment of patients with MPS. Sixty-four patients (55 female and 9 male) with MPS in their neck and shoulders participated in the study with mean age of 33.1 ± 6.4 years. Participants were randomly allocated to aerobic exercise plus acupuncture (n = 32) or acupuncture alone (n = 32) groups. Outcome measurements included visual analog scale, pressure pain threshold, neck disability index, and quality of life that was measured with QoL-SF36 scale. Each group received 10 sessions of acupuncture in combination with aerobic exercise or acupuncture alone. The outcome measures were evaluated at baseline, at the end of the last treatment session, and at 1-month follow-up visit. While participants were waiting for their 1-month follow-up visit, the patients who received combination therapy were asked to continue their aerobic exercise by jogging 40 minutes a day. Although mean visual analog scale, pressure pain threshold, neck disability index, and QoL-SF36 were significantly improved in both groups (p < 0.001), there was no statistically significant difference among the measures between the two groups throughout the evaluated sessions. The interaction effect of time and groups did not show any significant difference among the outcome measures (p > 0.29).

30 September 2019 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
MHMazyar Hashemilar
Mazyar Hashemilar
MKMohammad Khalili
Mohammad Khalili
NRNasim Rezaeimanesh
Nasim Rezaeimanesh
ESElyar Sadeghi-Hokmabadi
Elyar Sadeghi-Hokmabadi
SRSevin Rasulzade
Sevin Rasulzade
DODaryoush Savadi Osgouei
Daryoush Savadi Osgouei
Purpose: Malnutrition is extensively prevalent amongst critically ill patients afflicted by ischemic stroke (IS). This study purpose was to evaluate the protein whey effect on inflammatory and antioxidant markers and functional prognosis in acute IS patients. Methods: out of 42 patients with acute IS who were referred to Imam Reza Educational Hospital, Tabriz, Iran, 40 patients participated in the study. Twenty-one patients as control group received the hospital routine formula, and 19 patients as intervention group received 20 g/daily of whey protein through oral gavage. Inflammation and oxidative stress indicators (e.g., albumin, malondialdehyde (MDA), total antioxidant capacity (TAC), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and high sensitivity C reactive protein (hs-CRP)and clinical variables included in were evaluated using National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) during admission and also 3 weeks after intervention. Results: Whey protein supplementation significantly decreased the NIHSS and mRS scores, TNF-α, IL-6, and hs-CRP by passing 3 weeks from intervention (P<0.05). However, whey formula had no significant effect on other markers including albumin, and MDA. The hs-CRP (P = 0.02) reduction was significantly higher in whey protein group in comparison with control group. Conclusion: Whey protein supplementation reduced inflammation markers in those patients with IS. However, these changes should be studied in larger-scale trials.

24 June 2019 in Trials
Verified
Journal Article
Open access
PDF file
DADawood Aghamohammadi
Dawood Aghamohammadi
HAHormoz Ayromlou
Hormoz Ayromlou
NDNeda Dolatkhah
Neda Dolatkhah
FJFatemeh Jahanjoo
Fatemeh Jahanjoo
SSSeyed Kazem Shakouri
Seyed Kazem Shakouri
The relationship between gut dysbiosis and inflammatory diseases including multiple sclerosis (MS) is presently recognized as an important health issue. It has been established that some bacterial probiotic strains are effective in treating MS. This study will investigate the effect of yeast probiotic Saccharomyces boulardii (SB) supplements on mental health, quality of life, fatigue, pain, and indices of inflammation and oxidative stress in MS patients. In this double-blind randomized controlled two-group parallel trial, 50 MS patients who meet the inclusion criteria will be recruited from outpatient settings. They will be randomly allocated to 4 months of daily placebo or the SB probiotic intervention. Blood samples will be taken from each participant at the baseline and after the intervention period to assess inflammation and oxidative stress. The primary endpoint will be the changes in their mental health evaluated by the 28-item General Health Questionnaire. The secondary endpoints include changes in: (1) quality of life, evaluated by the 36-item Short Form Questionnaire, (2) fatigue, evaluated by the Fatigue Severity Scale, (3) pain, evaluated by a visual analogue scale, and (4) serum levels of indices of inflammatory stress (high-sensitivity C-reactive protein) and oxidative stress (malondialdehyde and total antioxidant capacity). Moreover, any adverse events and side effects due to the intervention will be documented. There is a need to discover safe and practical methods for managing the symptoms of MS. This trial will gather evidence on the effects of a probiotic. Iranian Clinical Trial Registry, IRCT20161022030424N1 . Registered on 9 April 2018.

23 February 2021 in BioFactors
Verified
Journal Article
Closed access
PDF file
SDSanam Dolati
Sanam Dolati
SSSeyed Kazem Shakouri
Seyed Kazem Shakouri
NDNeda Dolatkhah
Neda Dolatkhah
MYMehdi Yousefi
Mehdi Yousefi
FJFarhad Jadidi-Niaragh
Farhad Jadidi-Niaragh
SSSarvin Sanaie
Sarvin Sanaie